BETA

6 Amendments of Tomislav SOKOL related to 2023/2081(INI)

Amendment 18 #
Motion for a resolution
Recital D a (new)
Da. whereas there are several voluntary front-of-pack nutrition labelling schemes present currently within the EU single market which cause its fragmentation and may confuse consumers;
2023/10/16
Committee: ENVI
Amendment 33 #
Motion for a resolution
Recital F a (new)
Fa. Whereas it has been estimated that in the EU in 2017 over 950,000 deaths (one out of five) and over 16 million lost healthy life years were attributable to unhealthy diets, mainly cardiovascular diseases and cancers;
2023/10/16
Committee: ENVI
Amendment 92 #
Motion for a resolution
Paragraph 6 a (new)
6a. Calls on the European Commission to present as soon as possible a science based legislative proposal on harmonized and mandatory front-of-pack nutrition labeling which will respect the specificities of certain food products such as olive oil;
2023/10/16
Committee: ENVI
Amendment 113 #
Motion for a resolution
Paragraph 11
11. Considers it appropriate to explore the concept of ‘traditional use data’ in the efficacy assessment of health claims on plants used in food, taking into account the current regime for traditional herbal medicinal products; invites the Commission to assess whether the acceptance of traditional use evidence for the efficacy substantiation of health claims on botanicals would necessitate the creation of a separate category within the NHCR;deleted
2023/10/16
Committee: ENVI
Amendment 115 #
Motion for a resolution
Paragraph 11 a (new)
11a. Considers it essential to promptly review, in line with the provisions of Regulation (EC) No 1924/2006, the yet-to- be-assessed health claims related to botanicals in foods, especially for claims currently on the 'on hold list', ensuring the rejection of any previously negatively assessed claims to guarantee consumer protection;
2023/10/16
Committee: ENVI
Amendment 116 #
Motion for a resolution
Paragraph 12
12. Underlines that regulatory changes regarding the substantiation of claims on botanicals would need to be accompanied by the harmonisation of the safety framework for botanicals; emphasises the key importance of safety in use and advocates for regular reviews to be performed if claims were to be authorised based on ‘traditional use data’; insists on mandatory product labelling indicating claims authorised based on ‘traditional use data’ and advising that a physician should be consulted to ensure safe use and to avoid interactions with existing treatments or medical conditions;deleted
2023/10/16
Committee: ENVI